The DOI matches its Crossref record.
Predictive Value of Alexithymia: A Prospective Study in Somatizing Patients
Abstract
In the present study, the potential role of alexithymia in predicting the long-term treatment outcome was investigated prospectively in 30 patients with DSM-III-R somatoform disorders and anxiety disorders. Using SCID interviews, diagnoses were assessed before inpatient treatment and 2 years after discharge. Patients who met criteria for DSM-III-R undifferentiated somatoform disorder at follow-up exhibited higher pretreatment alexithymia scores (as measured by the TAS) as compared with patients who showed remission of their somatoform disorder or patients who never had met criteria for a somatoform disorder. As a result stepwise logistic regression analyses, high alexithymia scores emerged as a significant predictor of persistent somatization, independent of other measures of psychopathology, sociodemographic variables, and measures of illness severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because alexithymia was found to be related to impoverished general functioning in somatoform disorders (2, 11–21), following the classification of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-TR (22) and other precursors of SSRD, as described in DSM-5 (23), general functioning also may be a relevant outcome of treatment.”
Citations
Cited by
Sorted by citations
Recent Developments in Alexithymia Theory and Research
Taylor, G. J. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500203 · Cited by 755
New Trends in Alexithymia Research
Taylor, G. J., & Bagby, R. M. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000075537 · Cited by 653
“And in a study of psychiatric inpatients with anxiety or somatoform disorders who were treated with cognitive and behavioural therapies for a minimum of 8 weeks and reassessed 2 years later, alexithymia was a significant predictor of persistent somatization [”
BackgroundLumley, M. A., Neely, L. C., & Burger, A. J. (2007) · Journal of Personality Assessment · doi:10.1080/00223890701629698 · Cited by 535
“Alexithymia predicts poorer outcomes of treatment for anxiety and somatoform disorders (Bach & Bach, 1995), depression (Ogrodniczuk, Piper, & Joyce, 2004), alcoholism (Cleland, Magura, Foote, Rosenblum, & Kosanke, 2005; Loas, Fremaux, Otmani, Lecercle, & Delahousse, 1997), functional…”
De Gucht, V., & Heiser, W. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00467-1 · Cited by 311
Alexithymia and Somatization in General Population
Mattila, A. K., Kronholm, E., Jula, A., Salminen, J. K., Koivisto, A., Mielonen, R.-L., & Joukamaa, M. I. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816ffc39 · Cited by 277
“Bach and Bach (62) performed a 2-year follow-up study on patients with medically unexplained symptoms and found a high alexithymia score to be predictive of an undifferentiated somatoform disorder at follow-up.”
BackgroundInfluential
Metadata
- Authors
- Bach, M., & Bach, D.
- Affiliations
- University of Vienna (AT)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2010-02-18
- Volume
- 64
- Issue
- 1
- Pages
- 43-48
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2039507729
- Cited by
- 123
- References
- 0
- Citations by year
- 2025: 3 · 2024: 4 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- alexithymia, somatoform disorders, somatization, treatment outcome prediction, long-term remission, anxiety disorders, undifferentiated somatoform disorder, disease severity
- MeSH terms
- Adolescent, Adult, Affective Symptoms, Anxiety Disorders, Behavior Therapy, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Psychometrics, Sick Role, Somatoform Disorders, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
